Premium
Trupanion Inc (TRUP)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Mr. John GallagherCOO | -3,60k | 78,15k | Automatic Disposition | 21,69 | 33,07k | -9,83% |
| 2026-05-22 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | 312,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,46M | 0,02% |
| 2026-05-22 | Mr. Simon WheelerExec. VP of International Business | -1,02k | 22,34k | Derivative Exercise and Sale | 21,86 - 21,98 | 24,24k | - |
| 2026-05-22 | Mr. Simon WheelerExec. VP of International Business | 1,15k | 0,00 | Derivative Exercise and Retained Stock | - | 24,24k | 4,99% |
| 2026-05-22 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -7,49k | 164,57k | Derivative Exercise and Sale | 21,86 - 21,98 | 176,38k | - |
| 2026-05-22 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 11,55k | 0,00 | Derivative Exercise and Retained Stock | - | 176,38k | 7,01% |
| 2026-05-22 | Ms. Brenna McGibneyChief Administrative Officer | -3,44k | 75,55k | Derivative Exercise and Sale | 21,86 - 21,98 | 11,45k | - |
| 2026-05-22 | Ms. Brenna McGibneyChief Administrative Officer | 2,99k | 0,00 | Derivative Exercise and Retained Stock | - | 11,45k | 35,40% |
| 2026-05-25 | Mr. Fawwad QureshiCFO | -3,75k | 82,67k | Derivative Exercise and Sale | 21,86 - 22,17 | 2,08k | - |
| 2026-05-27 | Mr. Fawwad QureshiCFO | -3,92k | 87,07k | Automatic Disposition | 22,17 - 22,63 | 2,08k | -65,35% |
| 2026-05-22 | Mr. Asher Benjamin BearmanChief Legal Officer | 1,77k | 0,00 | Derivative Exercise and Retained Stock | - | 72,24k | 2,50% |
| 2026-05-22 | Mr. Asher Benjamin BearmanChief Legal Officer | -844,00 | 18,55k | Derivative Exercise and Sale | 21,86 - 21,98 | 72,24k | - |
| 2026-05-22 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -1,18k | 25,93k | Derivative Exercise and Sale | 21,86 - 21,98 | 76,24k | - |
| 2026-05-22 | Mr. John GallagherCOO | 5,14k | 0,00 | Derivative Exercise and Retained Stock | - | 36,67k | 16,31% |
| 2026-05-22 | Mr. Fawwad QureshiCFO | -3,99k | 87,68k | Sale to Issuer | 21,98 | 2,08k | -65,72% |
| 2026-05-22 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 3,68k | 0,00 | Derivative Exercise and Retained Stock | - | 76,24k | 5,07% |
| 2026-05-22 | Mr. Howard Elliot RubinIndependent Director | 318,00 | 0,00 | Derivative Exercise and Retained Stock | - | 232,87k | 0,14% |
| 2026-05-22 | Mr. Fawwad QureshiCFO | 9,99k | 0,00 | Derivative Exercise and Retained Stock | - | 2,08k | -126,30% |
| 2026-05-22 | Mr. Bradley S. PowellIndependent Director | 639,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,91k | 50,43% |
| 2026-05-22 | Mr. John GallagherCOO | -1,65k | 36,27k | Derivative Exercise and Sale | 21,86 - 21,98 | 36,67k | - |
| 2026-04-28 | Mr. John GallagherCOO | -431,00 | 11,84k | Automatic Disposition | 27,47 | 31,53k | -1,35% |
| 2026-03-30 | Mr. John GallagherCOO | -430,00 | 10,95k | Automatic Disposition | 25,47 | 31,96k | -1,33% |
| 2026-03-04 | Ms. Emily DreyerChief Revenue Officer | -7,79k | 219,32k | Vente | 28,15 | 35,63k | -17,95% |
| 2026-02-27 | Mr. John GallagherCOO | -5,28k | 140,08k | Automatic Disposition | 26,52 | 32,39k | -14,02% |
| 2026-02-27 | Mr. Fawwad QureshiCFO | -2,84k | 75,08k | Automatic Disposition | 26,46 | 0,00 | -100,00% |
| 2026-02-25 | Mr. Fawwad QureshiCFO | 2,84k | 0,00 | Derivative Exercise and Retained Stock | - | 2,84k | - |
| 2026-02-25 | Mr. Fawwad QureshiCFO | -913,00 | 24,38k | Derivative Exercise and Sale | 26,70 | 2,84k | - |
| 2026-02-25 | Mr. Fawwad QureshiCFO | -4,65k | 118,96k | Automatic Disposition | 25,61 | 2,84k | -62,08% |
| 2026-02-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 2,74k | 0,00 | Derivative Exercise and Retained Stock | - | 164,83k | 1,69% |
| 2026-02-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -1,78k | 47,42k | Derivative Exercise and Sale | 26,70 | 164,83k | - |
| 2026-02-25 | Ms. Brenna McGibneyChief Administrative Officer | 303,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,45k | 3,72% |
| 2026-02-25 | Ms. Brenna McGibneyChief Administrative Officer | -343,00 | 9,16k | Derivative Exercise and Sale | 26,70 | 8,45k | - |
| 2026-02-25 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 702,00 | 0,00 | Derivative Exercise and Retained Stock | - | 72,56k | 0,98% |
| 2026-02-25 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -223,00 | 5,95k | Derivative Exercise and Sale | 26,70 | 72,56k | - |
| 2026-02-25 | Ms. Emily DreyerChief Revenue Officer | 1,38k | 0,00 | Derivative Exercise and Retained Stock | - | 43,42k | 3,29% |
| 2026-02-25 | Ms. Emily DreyerChief Revenue Officer | -443,00 | 11,83k | Derivative Exercise and Sale | 26,70 | 43,42k | - |
| 2026-02-25 | Mr. Asher Benjamin BearmanChief Legal Officer | 189,00 | 0,00 | Derivative Exercise and Retained Stock | - | 70,48k | 0,27% |
| 2026-02-25 | Mr. Asher Benjamin BearmanChief Legal Officer | -116,00 | 3,10k | Derivative Exercise and Sale | 26,70 | 70,48k | - |
| 2026-02-25 | Mr. John GallagherCOO | 956,00 | 0,00 | Derivative Exercise and Retained Stock | - | 37,67k | 2,60% |
| 2026-02-25 | Mr. John GallagherCOO | -304,00 | 8,12k | Derivative Exercise and Sale | 26,70 | 37,67k | - |
| 2026-02-25 | Mr. Simon WheelerExec. VP of International Business | 171,00 | 0,00 | Derivative Exercise and Retained Stock | - | 23,09k | 0,75% |
| 2026-02-25 | Mr. Simon WheelerExec. VP of International Business | -151,00 | 4,03k | Derivative Exercise and Sale | 26,70 | 23,09k | - |
| 2026-02-25 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | 946,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,46M | 0,07% |
| 2026-02-22 | Ms. Brenna McGibneyChief Administrative Officer | 2,06k | 0,00 | Derivative Exercise and Retained Stock | - | 8,15k | 33,74% |
| 2026-02-22 | Ms. Brenna McGibneyChief Administrative Officer | -2,43k | 66,00k | Derivative Exercise and Sale | 27,16 | 8,15k | - |
| 2026-02-22 | Mr. Simon WheelerExec. VP of International Business | -1,40k | 38,13k | Derivative Exercise and Sale | 27,16 | 22,92k | - |
| 2026-02-22 | Mr. Simon WheelerExec. VP of International Business | 1,59k | 0,00 | Derivative Exercise and Retained Stock | - | 22,92k | 7,44% |
| 2026-02-22 | Mr. Howard Elliot RubinIndependent Director | 318,00 | 0,00 | Derivative Exercise and Retained Stock | - | 232,55k | 0,14% |
| 2026-02-22 | Mr. Bradley S. PowellIndependent Director | 638,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,27k | 101,43% |
| 2026-02-22 | Ms. Emily DreyerChief Revenue Officer | 2,53k | 0,00 | Derivative Exercise and Retained Stock | - | 42,04k | 6,39% |
| 2026-02-22 | Ms. Emily DreyerChief Revenue Officer | -1,06k | 28,87k | Derivative Exercise and Sale | 27,16 | 42,04k | - |
| 2026-02-22 | Mr. Fawwad QureshiCFO | 4,65k | 0,00 | Derivative Exercise and Retained Stock | - | 4,65k | - |
| 2026-02-22 | Mr. Fawwad QureshiCFO | -1,83k | 49,68k | Derivative Exercise and Sale | 27,16 | 4,65k | - |
| 2026-02-22 | Mr. Asher Benjamin BearmanChief Legal Officer | 1,02k | 0,00 | Derivative Exercise and Retained Stock | - | 70,29k | 1,47% |
| 2026-02-22 | Mr. Asher Benjamin BearmanChief Legal Officer | -609,00 | 16,54k | Derivative Exercise and Sale | 27,16 | 70,29k | - |
| 2026-02-22 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 3,49k | 0,00 | Derivative Exercise and Retained Stock | - | 71,86k | 5,11% |
| 2026-02-22 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -1,47k | 39,93k | Derivative Exercise and Sale | 27,16 | 71,86k | - |
| 2026-02-22 | Mr. John GallagherCOO | 4,85k | 0,00 | Derivative Exercise and Retained Stock | - | 36,71k | 15,23% |
| 2026-02-22 | Mr. John GallagherCOO | -1,91k | 51,82k | Derivative Exercise and Sale | 27,16 | 36,71k | - |
| 2026-02-22 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 11,80k | 0,00 | Derivative Exercise and Retained Stock | - | 162,09k | 7,85% |
| 2026-02-22 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -4,06k | 110,27k | Derivative Exercise and Sale | 27,16 | 162,09k | - |
| 2026-02-22 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | 6,56k | 0,00 | Derivative Exercise and Retained Stock | - | 1,45M | 0,45% |
| 2026-01-28 | Mr. John GallagherCOO | -430,00 | 13,62k | Automatic Disposition | 31,67 | 31,86k | -1,33% |
| 2026-01-09 | Dr. Murray Bruce LowLead Independent Director | 23,21k | 198,94k | Derivative Exercise and Retained Stock | 8,57 | 154,53k | 17,68% |
| 2025-12-29 | Mr. John GallagherCOO | -430,00 | 16,15k | Automatic Disposition | 37,55 | 32,29k | -1,31% |
| 2025-12-19 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -8,00k | 231,56k | Derivative Exercise and Sale | 8,93 - 37,88 | 150,29k | - |
| 2025-12-19 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -1,61k | 60,84k | Automatic Disposition | 37,91 | 150,29k | -1,06% |
| 2025-11-28 | Mr. John GallagherCOO | -6,38k | 222,28k | Automatic Disposition | 34,82 | 32,72k | -16,32% |
| 2025-11-25 | Mr. Simon WheelerExec. VP of International Business | 688,00 | 0,00 | Derivative Exercise and Retained Stock | - | 21,33k | 3,33% |
| 2025-11-25 | Mr. Simon WheelerExec. VP of International Business | -608,00 | 21,50k | Derivative Exercise and Sale | 35,36 | 21,33k | - |
| 2025-11-25 | Ms. Emily DreyerChief Revenue Officer | 1,11k | 0,00 | Derivative Exercise and Retained Stock | - | 39,51k | 2,89% |
| 2025-11-25 | Ms. Emily DreyerChief Revenue Officer | -717,00 | 25,35k | Derivative Exercise and Sale | 35,36 | 39,51k | - |
| 2025-11-25 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 701,00 | 0,00 | Derivative Exercise and Retained Stock | - | 68,37k | 1,04% |
| 2025-11-25 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -224,00 | 7,92k | Derivative Exercise and Sale | 35,36 | 68,37k | - |
| 2025-11-25 | Mr. John GallagherCOO | 767,00 | 0,00 | Derivative Exercise and Retained Stock | - | 39,10k | 2,00% |
| 2025-11-25 | Mr. John GallagherCOO | -493,00 | 17,43k | Derivative Exercise and Sale | 35,36 | 39,10k | - |
| 2025-11-25 | Ms. Brenna McGibneyChief Administrative Officer | 303,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,09k | 5,23% |
| 2025-11-25 | Ms. Brenna McGibneyChief Administrative Officer | -344,00 | 12,16k | Derivative Exercise and Sale | 35,36 | 6,09k | - |
| 2025-11-25 | Mr. Fawwad QureshiCFO | -3,75k | 132,80k | Derivative Exercise and Sale | 35,36 - 35,45 | 0,00 | - |
| 2025-11-26 | Mr. Fawwad QureshiCFO | -3,93k | 139,20k | Automatic Disposition | 35,45 | 0,00 | -100,00% |
| 2025-11-25 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | -946,00 | 42,29k | Derivative Exercise and Sale | 44,70 | 1,45M | - |
| 2025-11-25 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | -29,42k | 1,32M | Vente | 44,70 | 1,45M | -1,99% |
| 2025-11-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 4,52k | 0,00 | Derivative Exercise and Retained Stock | - | 151,90k | 3,06% |
| 2025-11-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -8,00k | 211,04k | Derivative Exercise and Sale | 8,93 - 35,31 | 151,90k | - |
| 2025-11-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -1,80k | 63,66k | Automatic Disposition | 35,31 | 151,90k | -1,17% |
| 2025-11-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -1,78k | 62,80k | Sale to Issuer | 35,36 | 151,90k | -1,16% |
| 2025-11-24 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | 6,56k | 0,00 | Derivative Exercise and Retained Stock | - | 1,45M | 0,46% |
| 2025-11-24 | Mr. Bradley S. PowellIndependent Director | 629,00 | 0,00 | Derivative Exercise and Retained Stock | - | 629,00 | - |
| 2025-11-24 | Mr. Howard Elliot RubinIndependent Director | 318,00 | 0,00 | Derivative Exercise and Retained Stock | - | 232,23k | 0,14% |
| 2025-11-24 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 9,62k | 0,00 | Derivative Exercise and Retained Stock | - | 150,96k | 6,80% |
| 2025-11-24 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -6,24k | 220,79k | Derivative Exercise and Sale | 35,40 | 150,96k | - |
| 2025-11-24 | Ms. Emily DreyerChief Revenue Officer | 2,56k | 0,00 | Derivative Exercise and Retained Stock | - | 38,40k | 7,15% |
| 2025-11-24 | Ms. Emily DreyerChief Revenue Officer | -1,03k | 36,36k | Derivative Exercise and Sale | 35,40 | 38,40k | - |
| 2025-11-24 | Mr. Simon WheelerExec. VP of International Business | 1,59k | 0,00 | Derivative Exercise and Retained Stock | - | 20,64k | 8,32% |
| 2025-11-24 | Mr. Simon WheelerExec. VP of International Business | -1,40k | 49,70k | Derivative Exercise and Sale | 35,40 | 20,64k | - |
| 2025-11-24 | Mr. John GallagherCOO | 5,95k | 0,00 | Derivative Exercise and Retained Stock | - | 38,34k | 18,38% |
| 2025-11-24 | Mr. John GallagherCOO | -3,41k | 120,54k | Derivative Exercise and Sale | 35,40 | 38,34k | - |
| 2025-11-24 | Ms. Brenna McGibneyChief Administrative Officer | 2,09k | 0,00 | Derivative Exercise and Retained Stock | - | 5,79k | 56,30% |
| 2025-11-24 | Ms. Brenna McGibneyChief Administrative Officer | -2,40k | 84,92k | Derivative Exercise and Sale | 35,40 | 5,79k | - |
| 2025-11-24 | Mr. Fawwad QureshiCFO | 3,93k | 0,00 | Derivative Exercise and Retained Stock | - | 3,93k | - |
| 2025-11-24 | Mr. Fawwad QureshiCFO | -2,55k | 90,09k | Derivative Exercise and Sale | 35,40 | 3,93k | - |
| 2025-11-24 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 67,67k | 5,87% |
| 2025-11-24 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -1,21k | 42,73k | Derivative Exercise and Sale | 35,40 | 67,67k | - |
| 2025-11-20 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | 2,00k | 29,90k | Derivative Exercise and Retained Stock | 14,95 | 27,22k | 7,93% |
| 2025-10-27 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -6,00k | 208,76k | Derivative Exercise and Sale | 8,93 - 43,72 | 141,35k | - |
| 2025-10-27 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -2,88k | 126,15k | Automatic Disposition | 43,74 | 141,35k | -2,00% |
| 2025-09-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -2,96k | 124,00k | Automatic Disposition | 41,88 | 144,23k | -2,01% |
| 2025-09-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -6,00k | 197,74k | Derivative Exercise and Sale | 8,93 - 41,89 | 144,23k | - |
| 2025-02-27 | Mr. Howard Elliot RubinIndependent Director | 641,00 | 0,00 | Derivative Exercise and Retained Stock | - | 231,91k | 0,28% |
| 2025-09-03 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | -19,63k | 879,23k | Vente | 44,79 | 1,44M | -1,35% |
| 2025-09-02 | Mr. Fawwad QureshiCFO | -6,45k | 291,29k | Automatic Disposition | 45,15 | 0,00 | -100,00% |
| 2025-05-22 | Mr. Darryl Graham Andrew RawlingsFounder & Chair of the Board | 15,02k | 0,00 | Derivative Exercise and Retained Stock | - | 1,49M | 1,02% |
| 2025-08-25 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 701,00 | 0,00 | Derivative Exercise and Retained Stock | - | 63,91k | 1,11% |
| 2025-08-25 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -223,00 | 10,22k | Derivative Exercise and Sale | 45,83 | 63,91k | - |
| 2025-08-25 | Ms. Emily DreyerChief Revenue Officer | 1,38k | 0,00 | Derivative Exercise and Retained Stock | - | 35,84k | 4,01% |
| 2025-08-25 | Ms. Emily DreyerChief Revenue Officer | -443,00 | 20,30k | Derivative Exercise and Sale | 45,83 | 35,84k | - |
| 2025-08-25 | Mr. John GallagherCOO | 956,00 | 0,00 | Derivative Exercise and Retained Stock | - | 32,38k | 3,04% |
| 2025-08-25 | Mr. John GallagherCOO | -303,00 | 13,89k | Derivative Exercise and Sale | 45,83 | 32,38k | - |
| 2025-08-25 | Ms. Brenna McGibneyChief Administrative Officer | 303,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,71k | 8,91% |
| 2025-08-25 | Ms. Brenna McGibneyChief Administrative Officer | -343,00 | 15,72k | Derivative Exercise and Sale | 45,83 | 3,71k | - |
| 2025-08-25 | Mr. Fawwad QureshiCFO | -3,75k | 171,33k | Derivative Exercise and Sale | 45,56 - 45,83 | 6,45k | - |
| 2025-08-26 | Mr. Fawwad QureshiCFO | -829,00 | 37,77k | Automatic Disposition | 45,56 | 6,45k | -11,39% |
| 2025-08-25 | Mr. Simon WheelerExec. VP of International Business | 688,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,06k | 3,75% |
| 2025-08-25 | Mr. Simon WheelerExec. VP of International Business | -608,00 | 27,86k | Derivative Exercise and Sale | 45,83 | 19,06k | - |
| 2025-08-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 2,74k | 0,00 | Derivative Exercise and Retained Stock | - | 147,19k | 1,90% |
| 2025-08-25 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -1,78k | 81,35k | Derivative Exercise and Sale | 45,83 | 147,19k | - |
| 2025-08-22 | Mr. John GallagherCOO | 4,46k | 0,00 | Derivative Exercise and Retained Stock | - | 31,43k | 16,55% |
| 2025-08-22 | Mr. John GallagherCOO | -1,44k | 66,91k | Derivative Exercise and Sale | 46,63 | 31,43k | - |
| 2025-08-22 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | 15,15k | 0,00 | Derivative Exercise and Retained Stock | - | 144,45k | 11,72% |
| 2025-08-22 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -9,83k | 458,33k | Derivative Exercise and Sale | 46,63 | 144,45k | - |
| 2025-08-22 | Dr. Steve WeinrauchChief Veterinary & Product Officer | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 63,21k | 6,31% |
| 2025-08-22 | Dr. Steve WeinrauchChief Veterinary & Product Officer | -1,21k | 56,24k | Derivative Exercise and Sale | 46,63 | 63,21k | - |
| 2025-08-22 | Ms. Brenna McGibneyChief Administrative Officer | 2,09k | 0,00 | Derivative Exercise and Retained Stock | - | 3,40k | 158,31% |
| 2025-08-22 | Ms. Brenna McGibneyChief Administrative Officer | -2,40k | 111,91k | Derivative Exercise and Sale | 46,63 | 3,40k | - |
| 2025-06-02 | Ms. Brenna McGibneyChief Administrative Officer | -2,39k | 107,96k | Vente | 45,17 | 3,40k | -41,26% |
| 2025-08-22 | Mr. Fawwad QureshiCFO | 3,74k | 0,00 | Derivative Exercise and Retained Stock | - | 7,28k | 105,36% |
| 2025-08-22 | Mr. Fawwad QureshiCFO | -2,74k | 127,72k | Derivative Exercise and Sale | 46,63 | 7,28k | - |
| 2025-08-22 | Mr. Simon WheelerExec. VP of International Business | 1,59k | 0,00 | Derivative Exercise and Retained Stock | - | 18,37k | 9,46% |
| 2025-08-22 | Mr. Simon WheelerExec. VP of International Business | -1,40k | 65,47k | Derivative Exercise and Sale | 46,63 | 18,37k | - |
| 2025-08-22 | Ms. Emily DreyerChief Revenue Officer | 2,72k | 0,00 | Derivative Exercise and Retained Stock | - | 34,46k | 8,56% |
| 2025-08-22 | Ms. Emily DreyerChief Revenue Officer | -873,00 | 40,71k | Derivative Exercise and Sale | 46,63 | 34,46k | - |
| 2025-06-06 | Ms. Margaret Rosemary Maria ToothPresident, CEO & Director | -200,00 | 8,16k | Derivative Exercise and Sale | 7,78 - 48,57 | 129,30k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
